Assignee
CHECKMATE PHARMACEUTICALS INC
US·4 granted patents·7 pending applications·13 citations·filing 2015–2025
Top patents by PatentIndex Score
11 records- 0195US10682365B2Combination tumor immunotherapyCHECKMATE PHARMACEUTICALS INC·Filed 2015·Granted Jun 16, 2020·10 cites·15 claims
- 0288US10907161B2Synthetic RIG-I-like receptor agonistsCHECKMATE PHARMACEUTICALS INC·Filed 2019·Granted Feb 2, 2021·3 cites·33 claims
- 0381US2026069624A1Combination tumor immunotherapyCHECKMATE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0470US12123003B2Synthetic RIG-I-like receptor agonistsCHECKMATE PHARMACEUTICALS INC·Filed 2020·Granted Oct 22, 2024·0 cites·18 claims
- 0569US2025034650A1Transcriptional biomarkers for response to innate immune activatorsCHECKMATE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0668US2025019695A1Packaging oligonucleotides into virus-like particlesCHECKMATE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0765US2020281953A1Combination tumor immunotherapyCHECKMATE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0859US12246031B2Compositions and methods for tumor immunotherapyCHECKMATE PHARMACEUTICALS INC·Filed 2019·Granted Mar 11, 2025·0 cites·5 claims
- 0955US2025255898A1Compositions and methods for tumor immunotherapyCHECKMATE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1046US2022378817A1Synthetic rig-i-like receptor agonistsCHECKMATE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1145US2019046638A1Fc RECEPTOR-MEDIATED DRUG DELIVERYCHECKMATE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →